Healthcare
Does Cannabis Work for Glaucoma? – What the Lastest Studies Say!
Does medical marijuana help with glaucoma?
Cannabis for Glaucoma – An Ongoing Debate In The Medical Community
Glaucoma is a name used to refer to conditions affecting the eye, specifically the optic nerve which we rely on heavily for good vision.
Glaucoma is usually associated with a gradual increase of pressure in the eye, called intraocular pressure. When intraocular pressure damages the optic nerve, this can lead to vision loss and even permanent blindness within the span of a few years if it isn’t treated. It can be tricky to diagnose it because during the early stages of glaucoma, many people don’t experience any pain or symptoms. The best way to diagnose it early to prevent loss of vision is to have regular checkups with your eye doctor.
Once you have glaucoma, you will likely need lifelong treatment. However, with early diagnosis, vision loss can be slowed down and permanent blindness can still be prevented.
Currently, treatment methods for glaucoma include prescription eyedrops which are designed to reduce eye pressure and improving fluid drainage from the eye. If intraocular pressure is severe, more than one type of eyedrop may be recommended. In addition, depending on how severe the glaucoma is, some patients may be prescribed oral medications and eye surgery on top of lifestyle changes.
However, cannabis has been shown to be promising in the treatment of glaucoma.
What The Latest Studies Say
At the moment, the medical community is still divided when it comes to the benefits of cannabis for glaucoma. Some agree that it does work because of the evidence, while others are still on the fence.
The studies backing up how cannabis can naturally reduce intraocular pressure dates back as far as 1971. In this study, 11 healthy participants were asked to go through eye exams before and after smoking 2 grams of marijuana. Researchers discovered that the changes observed varied from 4% increase to as much as 45% decrease in intraocular pressure. Further studies showed that some 65% of glaucoma patients experienced 30% pressure decrease after inhaling cannabis, and its positive effects lasted 3-4 hours. It should also be noted that the benefits of cannabis for glaucoma were dose-dependent.
According to Dr. Nick Andrew, a specialist eye surgeon, THC is the primary cannabinoid that works to reduce intraocular pressure by reducing the fluid that fills up the eye. He adds that THC eyedrops are recommended as the ideal administration route since the THC compounds only need to reach the eye, without having to pass through the nervous system.
Furthermore, the American Association of Ophthalmology says that since the effects last 3-4 hours, they don’t advise using cannabis to treat glaucoma for people who need to be sober in order to drive, operate heavy machinery, or go to work.
But this hasn’t stop people and dispensaries from recommending it. A 2020 study that was published in Ophthalmology Glaucoma journal revealed that 51% of dispensaries surveyed recommended marijuana use while others said they were either unsure or deferred recommendations. Additionally, they also found that 2.6% of glaucoma patients admitted to using cannabis. These figures show that even though many cannabis advocates are working hard to prove the benefits of the plant for glaucoma, many Americans are still not receiving the information and care that they need for a condition that’s difficult to treat.
“Few glaucoma specialists have recommended marijuana as a treatment for glaucoma and an even smaller percentage of patients report its use as a treatment for glaucoma,” wrote the authors. “In contrast, many dispensary employees endorse its use. As legal access and public acceptance of marijuana escalates, physicians should be aware of these perceptions when educating patients,” the authors concluded.
According to Dr. Bret A. Hughes, MD, many glaucoma patients are seeking alternative treatments for glaucoma. He explains how it works in the human body for treating this eye condition: “Humans have an endocannabinoid system with receptors that are stimulated by THC and CBD. The body also has naturally occurring cannabinoid receptor ligands, i.e., arachydonoylethanolamine and 2 arachydonoylglycerol, which mimic the effects of THC and CBD in the body.”
“Natural and synthetic cannabinoids interact with the endocannabinoid system to produce aqueous production, increase outflow, and provide neuroprotection,” he explained.
It’s also interesting to note that while cannabidiol (CBD), another powerful anti-inflammatory compound in cannabis that doesn’t get you high, has been used widely for treating many life-threatening conditions, this cannabinoid is not recommended for treating glaucoma. An animal study in 2019 found that CBD and THC has varying effects on eye pressure; while THC was beneficial in reducing eye pressure by as much as 30%, CBD could actually increase eye pressure, which is not good news for glaucoma patients.
Conclusion
Many patients around the country already use cannabis as part of their glaucoma treatments. If your glaucoma is still in its mild stages, cannabis can be of great help though it’s not meant to substitute all medication and treatment entirely.
Cannabinoids have shown potential in reducing the intraocular pressure associated with glaucoma. They also have neuroprotective properties, and we anticipate the development of THC eye drops that will greatly benefit glaucoma patients. There is still ongoing research to see how this can be executed because it’s a challenge considering the eye’s surface may not be able to absorb the cannabinoid eye drops. Water and oil-based eye drops didn’t work based on previous research, so scientists are further investigating which methods of administration will be more feasible in the future.
Economic Fraud
Fugitive Medicare Fraud Suspect Returned to US After Arrest in Türkiye
U.S. federal authorities have secured the return of a fugitive suspect accused of involvement in a massive Medicare fraud operation, following his arrest in Türkiye. The extradition marks a significant development in a major healthcare fraud investigation that allegedly cost the American healthcare system billions of dollars.
The suspect, Ibrahim Khaldoon Hilmi, is now in federal custody after spending more than a year outside the United States. Prosecutors are expected to move forward with criminal proceedings as investigators continue to examine what authorities describe as a sophisticated fraud network targeting public healthcare funds.
International Manhunt Ends with Arrest in Türkiye
According to federal investigators, Hilmi left the United States in May 2025 while authorities were building their case. Law enforcement agencies later tracked his location to Türkiye, where cooperation between U.S. and Turkish officials led to his detention.
Following the completion of legal and diplomatic procedures, the suspect was transferred to American custody. Officials described the operation as a successful example of international law enforcement collaboration in pursuing suspects accused of large-scale financial crimes.
A specialized FBI team reportedly traveled to Türkiye to coordinate the transfer and ensure the extradition process was completed smoothly.
Alleged Scheme Targeted Medicare Reimbursement System
Investigators allege that Hilmi played a central role in a fraudulent operation that exploited the Medicare reimbursement system through false claims and improper billing practices.
Authorities estimate that the alleged scheme involved financial losses equivalent to approximately ₹31,700 crore, making it one of the most significant healthcare fraud investigations in recent years.
While the allegations have yet to be tested in court, investigators believe the operation relied on complex financial transactions and coordinated activities designed to extract funds from a government healthcare program serving millions of beneficiaries.
Federal Agencies Expand Investigation
The case extends beyond a single suspect. Federal authorities are examining the potential involvement of additional individuals, businesses, and organizations believed to be connected to the alleged fraud network.
Investigators are reviewing banking records, financial transactions, corporate structures, and digital evidence to determine the full scope of the operation and identify any additional participants.
Officials indicated that tracing the movement of funds and uncovering potential links between entities remains a key focus of the ongoing investigation.
Healthcare Fraud Remains a Major Concern
Government agencies continue to treat Medicare fraud as a serious threat because it impacts taxpayer-funded healthcare resources intended for legitimate medical services.
Authorities argue that fraudulent claims can divert critical funding, increase administrative costs, and place additional pressure on public healthcare programs. As healthcare systems become increasingly digitized, fraud schemes have also become more sophisticated and difficult to detect.
Financial crime specialists note that modern healthcare fraud investigations often involve shell companies, layered transactions, and cross-border financial networks that require extensive forensic analysis.
Growing Importance of Global Law Enforcement Cooperation
The successful return of Hilmi highlights the increasing role of international cooperation in combating financial crime. Law enforcement agencies worldwide are relying more heavily on cross-border partnerships to locate and apprehend suspects who attempt to evade prosecution by relocating overseas.
Officials say such collaborations are essential as financial crimes become increasingly global in nature, involving multiple jurisdictions and complex international money flows.
Legal Proceedings Ahead
The U.S. Department of Justice is expected to present evidence against the suspect as court proceedings move forward. Prosecutors will seek to establish the extent of the alleged fraud and determine accountability among those involved.
The outcome of the case could influence future enforcement efforts aimed at protecting public healthcare programs and strengthening safeguards against large-scale financial misconduct.
For federal authorities, the extradition of Ibrahim Khaldoon Hilmi represents a major step in an ongoing campaign to crack down on healthcare fraud and recover public funds allegedly lost through criminal schemes.
Cyber Crime
Telangana Doctors Lose Nearly ₹30 Crore to Cyber Fraud Since September 2024
Cybercriminals have defrauded doctors across Telangana of nearly ₹30 crore since September 2024, prompting authorities to strengthen awareness campaigns and cybersecurity education within the healthcare sector.
The alarming figures were revealed during a cyber awareness programme organized by the Telangana Cyber Security Bureau (TGCSB) in Hyderabad. Senior officials warned that healthcare professionals are increasingly becoming targets of sophisticated online scams despite their educational and professional backgrounds.
Healthcare Professionals Under Growing Cyber Threat
Addressing representatives from various medical associations, TGCSB Director Shikha Goel highlighted the rising number of cybercrime incidents involving doctors and healthcare workers. She emphasized that cybercriminals are exploiting digital platforms to target individuals across all professions, including highly qualified medical practitioners.
Officials stressed that vigilance, awareness, and prompt reporting remain the strongest defenses against cyber fraud. The event focused on strengthening cooperation between law enforcement agencies and the medical fraternity to improve preparedness against evolving cyber threats.
More than 70 office-bearers from medical organizations across Telangana attended the session, including presidents, secretaries, treasurers, and senior representatives.
Investment Scams Responsible for Major Financial Losses
According to TGCSB data, at least 735 doctors have reported cybercrime-related incidents since September 2024, with total losses reaching approximately ₹29.88 crore.
Business and investment fraud emerged as the most damaging category, accounting for losses of ₹22.39 crore involving 127 victims. Investigators noted that fraudsters often lure professionals with promises of high returns, fake investment opportunities, and deceptive business schemes.
Authorities also reported a wide range of other cyber offences affecting doctors, including digital arrest scams, identity theft, impersonation fraud, fake advertisements, job-related scams, insurance fraud, cryptocurrency fraud, UPI-related cheating, matrimonial scams, and sextortion cases.
Authorities Stress Importance of Rapid Reporting
The Telangana Cyber Security Bureau urged victims to report cybercrime incidents immediately, especially during the critical “golden hour” after a fraudulent transaction occurs.
Officials explained that timely complaints through the national cybercrime helpline 1930 and the official cybercrime reporting portal can significantly improve the chances of freezing suspicious transactions and recovering stolen funds.
The bureau further warned that cybercriminals are employing increasingly advanced techniques to deceive victims, making awareness and quick action more important than ever.
Medical Associations Join Awareness Drive
Representatives from associations of paediatricians, cardiologists, dentists, orthopaedic surgeons, gynaecologists, and hospital administrators participated in the discussions. The groups pledged to work closely with authorities to spread cybersecurity awareness through hospitals, clinics, medical conferences, and professional training programmes.
Officials believe that expanding cyber awareness among healthcare professionals will play a key role in reducing financial fraud and strengthening digital security across the state’s medical community.
As cyber threats continue to evolve, law enforcement agencies are encouraging doctors and other professionals to remain cautious when responding to investment offers, unknown communications, and requests for sensitive financial information online.
Education News
AIIMS Gorakhpur Reservation Controversy: FIR Alleges Fake OBC Certificate Used Despite ₹80 Lakh Income
A major controversy has emerged at AIIMS Gorakhpur after allegations surfaced that reservation benefits were misused to secure a postgraduate medical seat. A criminal case has been registered against former AIIMS Gorakhpur Executive Director Dr. G.K. Pal and his son, Dr. Oro Prakash Pal, over the alleged use of a forged Other Backward Class (OBC) Non-Creamy Layer certificate for admission to an MD course.
The case has triggered widespread debate within medical and administrative circles, raising serious questions about transparency and oversight in admissions to premier medical institutions.
FIR Filed on Court’s Direction
The First Information Report (FIR) was registered at the AIIMS police station following directions from Chief Judicial Magistrate Tvishi Srivastava. According to the complaint, the alleged offence took place on August 30, 2024, when forged documents were purportedly used to obtain an MD seat under the OBC reservation quota.
Sources indicate that the matter was subsequently brought to the attention of the Union Ministry of Health, prompting internal reviews and administrative action.
Alleged Income Far Above Eligibility Threshold
Central to the allegations is the claim that Dr. G.K. Pal and his wife Parvati Pal have a combined annual income exceeding ₹80 lakh. Under existing reservation rules, families with such income levels are not eligible for OBC Non-Creamy Layer benefits.
Following the emergence of the controversy, Dr. Pal was first removed from his position at AIIMS Gorakhpur and later relieved of responsibilities at AIIMS Patna. He is currently posted at JIPMER Puducherry. With the registration of the FIR, officials suggest that further legal and departmental action may follow, depending on the outcome of the investigation.
Complaint Highlights Systemic Concerns
The complaint was filed by Ashutosh Kumar Mishra, a resident of Divyanagar in the Cantonment area. He alleged that the events related to the case occurred between January and September 2024. The complainant argued that misuse of reservation provisions by individuals in senior positions undermines the integrity of public institutions and erodes trust in the medical education system.
The case has reignited concerns over whether verification mechanisms for reservation certificates are robust enough, particularly in high-stakes admissions.
Impact on Medical Community
The allegations have sent shockwaves through the medical fraternity. Experts believe that if the claims are substantiated, the case could prompt a broader review of admission procedures and lead to stricter scrutiny of category certificates across institutions like AIIMS.
Authorities have stated that all relevant documents will be carefully examined before taking further steps. The outcome of the investigation is expected to have far-reaching implications for accountability and compliance in medical admissions.
Questions Await Answers
As the probe continues, several key issues remain unresolved: whether reservation norms were deliberately violated, how verification processes failed, and whether similar cases may surface in the future. For now, the focus remains on the investigation and its potential consequences.
-
Business3 years agoPot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms
-
Business3 years agoNew Mexico cannabis operator fined, loses license for alleged BioTrack fraud
-
Business3 years agoAlabama to make another attempt Dec. 1 to award medical cannabis licenses
-
Business3 years agoWashington State Pays Out $9.4 Million in Refunds Relating to Drug Convictions
-
Business3 years agoMarijuana companies suing US attorney general in federal prohibition challenge
-
Business3 years agoLegal Marijuana Handed A Nothing Burger From NY State
-
Business3 years agoCan Cannabis Help Seasonal Depression
-
Blogs3 years agoCannabis Art Is Flourishing On Etsy
